Blueprint Medicines Corpo... (BPMC)
106.09
3.53 (3.44%)
At close: Jan 15, 2025, 11:46 AM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 71.29M | 119.71M | 209.95M | 684.64M | 113.94M | 68.06M | 673.36M | 268.22M | 162.71M | 47.24M | 1.99M |
| Short-Term Investments | 639.36M | 825.28M | 267.17M | 187.21M | 369.62M | 425.95M | 273.05M | 162.09M | n/a | n/a | n/a |
| Long-Term Investments | 84.32M | 161.27M | 557.53M | 677.87M | 64.41M | n/a | n/a | 54.06M | n/a | n/a | n/a |
| Other Long-Term Assets | 40.89M | 26.78M | 19.81M | 11.09M | 15.39M | 10.71M | 5.87M | 2.12M | 1.82M | 169.00K | 283.00K |
| Receivables | 43.18M | 36.94M | 37.03M | 25.31M | 23.41M | 215.00K | n/a | 3.58M | 3.41M | n/a | n/a |
| Inventory | 21.22M | 29.70M | 21.82M | 8.58M | -434.02M | 1.00 | n/a | -54.06M | n/a | n/a | n/a |
| Other Current Assets | 33.35M | 35.02M | 18.06M | 22.02M | 9.82M | 5.35M | 11.94M | 2.69M | 4.29M | 1.03M | 361.00K |
| Total Current Assets | 808.39M | 1.05B | 554.02M | 927.76M | 516.79M | 499.79M | 685.50M | 220.43M | 170.42M | 48.27M | 2.45M |
| Property-Plant & Equipment | 115.65M | 115.20M | 120.86M | 101.67M | 111.11M | 29.63M | 24.36M | 6.19M | 6.66M | 1.48M | 1.40M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 240.86M | 303.25M | 698.20M | 790.63M | 190.91M | 40.34M | 30.23M | 62.37M | 8.48M | 1.65M | 1.69M |
| Total Assets | 1.05B | 1.35B | 1.25B | 1.72B | 707.69M | 540.12M | 715.74M | 282.80M | 178.90M | 49.92M | 4.13M |
| Account Payables | 4.71M | 2.73M | 8.33M | 4.37M | 4.79M | 3.30M | 3.74M | 2.21M | 2.46M | 814.00K | 1.41M |
| Deferred Revenue | 812.00K | 448.62M | 36.58M | 12.56M | 6.16M | 3.60M | 5.37M | 11.43M | 5.90M | 3.95M | 1.01M |
| Short-Term Debt | 81.41M | 27.43M | 16.19M | 15.87M | 13.65M | n/a | 3.23M | 3.13M | 3.84M | 1.57M | 567.00K |
| Other Current Liabilities | 127.99M | 153.07M | 113.74M | 98.00M | 81.88M | 53.42M | 30.54M | 11.75M | 6.44M | 4.11M | 890.00K |
| Total Current Liabilities | 214.92M | 183.23M | 149.76M | 130.80M | 106.48M | 60.32M | 42.89M | 28.51M | 18.64M | 6.76M | 3.15M |
| Long-Term Debt | 692.71M | 215.02M | 103.31M | 81.67M | 89.13M | 12.90M | 14.62M | 4.31M | 7.44M | 7.34M | 2.15M |
| Other Long-Term Liabilities | 6.21M | 436.97M | 3.34M | 7.24M | 7.81M | 5.32M | 4.26M | 1.09M | 1.09M | 394.00K | 323.00K |
| Total Long-Term Liabilities | 703.72M | 651.99M | 131.72M | 117.50M | 136.85M | 60.79M | 48.88M | 41.20M | 16.28M | 7.73M | 2.48M |
| Total Liabilities | 918.64M | 835.23M | 281.49M | 248.31M | 243.34M | 121.11M | 91.77M | 69.72M | 34.92M | 14.50M | 5.63M |
| Total Debt | 774.12M | 242.45M | 111.41M | 89.60M | 95.95M | 14.62M | 16.33M | 3.37M | 3.95M | 9.04M | 2.86M |
| Common Stock | 61.00K | 60.00K | 59.00K | 58.00K | 49.00K | 44.00K | 43.00K | 33.00K | 27.00K | 2.00K | 1K |
| Retained Earnings | -2.34B | -1.83B | -1.28B | -631.36M | -945.24M | -597.54M | -355.59M | -207.47M | -134.97M | -82.21M | -41.92M |
| Comprehensive Income | -3.50M | -10.44M | -4.13M | -5.21M | -2.54M | -180.00K | -269.00K | -18.00K | -2.08M | -1.55M | -924.00K |
| Shareholders Equity | 130.61M | 514.68M | 970.74M | 1.47B | 464.36M | 419.01M | 623.97M | 213.08M | 143.98M | 35.43M | -1.50M |
| Total Investments | 723.67M | 958.76M | 824.70M | 865.09M | 434.02M | 425.95M | 273.05M | 216.15M | n/a | n/a | n/a |